↓ Skip to main content

Antidepressant drugs for narcolepsy

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antidepressant drugs for narcolepsy
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd003724.pub3
Pubmed ID
Authors

Luca Vignatelli, Roberto D'Alessandro, Livia Candelise

Abstract

Narcolepsy is a disorder of the central nervous system, the main symptoms of which are excessive daytime sleepiness (EDS) and cataplexy (an abrupt and reversible decrease in or loss of muscle tone, affecting the limbs or trunk or both, elicited by emotional stimuli). Narcolepsy has an adverse impact on people's quality of life. Together with stimulant drugs (used to control EDS), antidepressants are usually recommended to counteract cataplexy. In addition, some antidepressants are also reported to improve EDS.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Australia 1 2%
United States 1 2%
Unknown 56 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 19%
Student > Doctoral Student 8 14%
Other 8 14%
Student > Master 7 12%
Student > Bachelor 6 10%
Other 19 32%
Readers by discipline Count As %
Medicine and Dentistry 29 49%
Psychology 7 12%
Unspecified 5 8%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 11 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2014.
All research outputs
#8,484,849
of 13,529,516 outputs
Outputs from Cochrane database of systematic reviews
#8,932
of 10,628 outputs
Outputs of similar age
#98,298
of 183,627 outputs
Outputs of similar age from Cochrane database of systematic reviews
#87
of 106 outputs
Altmetric has tracked 13,529,516 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,628 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,627 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.